In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Autifony Therapeutics, a UK-based biotech company specializing in hearing loss and tinnitus, has appointed John Hutchison as chief medical officer. 3 September 2015
Biotechnology
ACADIA Pharmaceuticals has submitted a New Drug Application to the US Food and Drug Administration seeking approval for Nuplazid (pimavanserin) for the treatment of psychosis associated with Parkinson’s disease. 3 September 2015
Biotechnology
UK biotech company Atopix Therapeutics has appointed Andrew Zambanini as chief medical officer. 3 September 2015
Pharmaceutical
Duchenne muscular dystrophy (DMD) specialist Summit Therapeutics has appointed Ralf Rosskamp as chief medical officer. 2 September 2015
Biotechnology
Oncology biotech company Halozyme has appointed Michael LaBarre as chief scientific officer. 25 August 2015
Pharmaceutical
Anglo-Swedish drug major AstraZeneca has appointed Sean Bohen as executive vice president of global medicines development and chief medical officer. 24 August 2015
Biotechnology
Biopharma company Endocyte has appointed Alison Armour as chief medical officer. 4 August 2015
Pharmaceutical
Germany’s Merck KGaA named Isabel De Paoli head of group communications effective March 9, 2016. She will succeed Walter Huber, who is set to retire in March next year. 30 July 2015
Pharmaceutical
Pharma giant Merck & Co on Tuesday said it has agreed to buy Israel-based drugmaker cCAM Biotherapeutics for as much as $605 million in a bid to expand its immuno-oncology portfolio. 29 July 2015
Biotechnology
US biotech major Gilead Sciences on Tuesday named William Lee the executive vice president (EVP) for research, and Brett Pletcher the EVP and general counsel. Both Mr Lee and Mr Pletcher will join the company’s senior leadership committee. 28 July 2015
Pharmaceutical
Privately-held pharma company Otic, focused on ear, nose and throat disorders, has appointed Gregory Flesher as chief executive and member of the board. 27 July 2015
Biotechnology
Privately-held biopharma company Wilson Therapeutics has appointed Carl Bjartmar as chief medical officer. 22 July 2015
Biotechnology
Synthetic biology specialist Intrexon Corp has appointed Jack Bobo as senior vice president, chief communications officer, Samuel Broder as senior vice president, head of health, and Joel Liffman as senior vice president, finance. 22 July 2015
Biotechnology
Human gene therapy specialist uniQure has appointed Charles Richard as senior vice president of research and development in neuroscience. 17 July 2015
Biotechnology
US biotech major Biogen announced on Friday that head of R&D Douglas Williams will leave the company at the end of July to become chief executive of an as-yet unnamed start-up biotechnology company. 11 July 2015
Biotechnology
Oncology immunotherapy specialist Advaxis has appointed Shelonitda Rose as vice president of clinical development. 8 July 2015
Pharmaceutical
Sanofi Pasteur MSD, the joint venture company between Sanofi and Merck, has appointed David Khougazian as president. 29 June 2015
Biotechnology
French biopharma company DBV Technologies has appointed Hugh Sampson as chief scientific officer. 26 June 2015
Pharmaceutical
UK developer of inhaled therapies Vectura has appointed James Ward-Lilley as chief executive and executive director. 24 June 2015
Pharmaceutical
Waypoint Capital, the business enterprise for investments associated with the Bertarelli family, has named Christopher Viehbacher as the managing partner of its US-based Gurnet Point Capital (GPC) fund. 24 June 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze